Showing only trials that are South East England

A study of Intravenous or Sub-Cut LY4152199 in Participants with previously treated B-Cell Cancers or Leukaemia

Measuring the safety and efficacy of LY4152199 in participants with previously treated B-Cell cancer or Leukaemia

Expected to end: 01/04/2027